If an underlying condition is responsible (liver disease, kidney disease, myeloproliferative disorder, or cancer), treating the underlying condition is the priority
Medication Interactions Research has not identified any interactions with specific medications
Semaglutide produces average weight loss of 12% to 15% depending on the trial and dose
Stable Gastric Pentadecapeptide BPC 157, Roberts Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selyes Stress Coping Response: Progress, Achievements, and the Future. Gut and liver vol
Fascial rupture disrupts the normal function of the foot and can promote further inflammation and pain
Warning: Do not exceed the recommended daily dose